SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-038614
Filing Date
2024-03-29
Accepted
2024-03-29 16:00:14
Documents
21
Period of Report
2024-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnlx-20240328.htm   iXBRL 8-K 44977
2 EX-10.1 rnlx-ex10_1.htm EX-10.1 1255758
3 GRAPHIC img184115036_0.jpg GRAPHIC 35848
4 GRAPHIC img184115036_1.jpg GRAPHIC 35848
5 GRAPHIC img184115036_2.jpg GRAPHIC 1069
6 GRAPHIC img184115036_3.jpg GRAPHIC 1238
7 GRAPHIC img184115036_4.jpg GRAPHIC 1084
8 GRAPHIC img184115036_5.jpg GRAPHIC 1266
9 GRAPHIC img184115036_6.jpg GRAPHIC 1266
10 GRAPHIC img184115036_7.jpg GRAPHIC 1262
11 GRAPHIC img184115036_8.jpg GRAPHIC 1033
  Complete submission text file 0000950170-24-038614.txt   1723723

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240328.xsd EX-101.SCH 52658
25 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240328_htm.xml XML 6091
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39387 | Film No.: 24804061
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)